Where is Moon Surgical based?

Moon Surgical is based in San Carlos, California, USA.

When was Moon Surgical founded?

Moon Surgical was founded in 2020.

What does Moon Surgical make?

Moon Surgical has 1 robot model on the DEPLOY registry: Maestro (Moon Surgical builds both physical robots and the AI that runs them).

Where does Moon Surgical operate robots?

Moon Surgical is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.

Is Moon Surgical safe?

Moon Surgical has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.

Moon Surgical · DEPLOY

Overview

Surgical-robotics company (Paris + San Carlos CA; CEO Anne Osdoit, chair Fred Moll) making the Maestro laparoscopic surgical-assistant robot with the shipped FDA-cleared ScoPilot AI (NVIDIA Holoscan).

Verified record

Verified deployments: None on file
Active incidents: None on file

DEPLOY Intelligence

Market intelligence for physical AI

Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.

Models (1)

View all models →

Current platform

Maestro

Moon Surgical (private, with offices in Paris and San Carlos, California; led by CEO Anne Osdoit, with Intuitive Surgical co-founder Fred Moll as board chair and backers including Sofinnova Partners and NVIDIA's venture arm NVentures) makes Maestro, a laparoscopic surgical-assistant and collaboration robot that holds and positions instruments and the endoscope alongside the surgeon rather than acting as a full master-slave teleoperation console, targeting the large pool of soft-tissue procedures unserved by teleoperated robots. The commercial Maestro received FDA 510(k) clearance under K240598 on June 5, 2024, and the company reports more than 1,100 patients treated across the US and Europe, on roughly $90 million-plus in funding. A notable AI distinction in this cohort: Maestro's ScoPilot is a genuinely shipped, FDA-cleared AI feature for intraoperative scope control, powered by NVIDIA Holoscan and cleared with a Predetermined Change Control Plan, rather than a mere demonstration, which sets Maestro apart from the teleoperation-only platforms here. A pathway correction worth recording: Maestro went the 510(k) route under K240598, not the de novo route sometimes assumed, with the contemporaneous de novo authorizations belonging to different companies such as Virtual Incision and MMI. The registry records Maestro at commercial maturity, an early-commercial collaborative-assist robot past its gating event, while noting that its CE mark status, exact installed-system count, and the more-than-1,100-patients figure are not independently verified.

surgicalView model →

Relationships

SSofinnova PartnersInvestor OOrbiMedInvestor SSectoral Asset ManagementInvestor

Current leadership (2)

Anne Osdoit Founding CEOIR-verified
Brice Gayet FounderIR-verified

Founders (2)

Anne Osdoitcofounderfounded 2018-01-01
Brice Gayetcofounderfounded 2018-01-01

Board (1)

Frederic Moll director

Safety record

No incidents on record for Moon Surgical.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Recent coverage

Moon Surgical in third-party press

Moon Surgical wins first FDA 510(k) clearance for Maestro surgical robotics system

Jun 25, 2026

Peer companies

Intuitive Surgical2 models
Johnson & Johnson2 models
Stryker2 models
Vantis2 models
Asensus Surgical1 model
Auris Health1 model

Financial state

Reporting basis: aggregator_estimate
Lifecycle stage: growth
Counterparty risk class: moderate

Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.

Funding rounds (2)

Series B2023-01-25
$82M(reported)
Investors: Sofinnova Partners (lead), OrbiMed
Series A2021-06-01
$16M(reported)
Investors: Sofinnova Partners (lead), Sectoral Asset Management

Regulatory filings (1)

K240598fda 510k · us_fdacleared2024-03-04
Linked models: Maestro

Sources (4)

Common questions

What is Moon Surgical?: Surgical-robotics company (Paris + San Carlos CA; CEO Anne Osdoit, chair Fred Moll) making the Maestro laparoscopic surgical-assistant robot with the shipped FDA-cleared ScoPilot AI (NVIDIA Holoscan).
Where is Moon Surgical based?: Moon Surgical is based in San Carlos, California, USA.
When was Moon Surgical founded?: Moon Surgical was founded in 2020.
What does Moon Surgical make?: Moon Surgical has 1 robot model on the DEPLOY registry: Maestro (Moon Surgical builds both physical robots and the AI that runs them).
Where does Moon Surgical operate robots?: Moon Surgical is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.
Is Moon Surgical safe?: Moon Surgical has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.

Methodology: Verified · 4 sources (2 primary) · last reviewed 2026-07-03

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-07-03

Sources by quality tier

2: unclassified; Unclassified source
1: primary-company-ir; Company IR disclosure
1: primary-fda-database; FDA database

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Peer companies

Intuitive Surgical2 models
Johnson & Johnson2 models
Stryker2 models
Vantis2 models
Asensus Surgical1 model
Auris Health1 model

In the press

Recent coverage mentioning Moon Surgical from third-party publications. Automatically surfaced; not part of the verified registry record.

AgentReconJun 25, 2026

Moon Surgical wins first FDA 510(k) clearance for Maestro surgical robotics system

Moon Surgical receives FDA 510(k) clearance for its Maestro table-mounted surgical robotics system for general surgery.

↗

Machine-readable surfaces

Markdown mirror: /companies/moon-surgical.md
RSS feed: /companies/moon-surgical/feed.xml
JSON-LD: embedded in this page’s head
REST API: /v1/companies/392e4009-60dd-429d-b989-033a7d4de53d
Revision history: /companies/moon-surgical/history
Data documentation: /data
Query this programmatically: Deploy MCP

Peer companies

Intuitive Surgical2 models
Johnson & Johnson2 models
Stryker2 models
Vantis2 models
Asensus Surgical1 model
Auris Health1 model

DEPLOY Intelligence Score

29.9/ 100

3.0vs 6 months ago

6-month trend

Peer rankingTop 8% of Surgical

Analysis

Clean safety record across 1 verified deployment. Deployment footprint remains limited relative to category peers.

Signal flags

New deploymentRecent pressFunding gap >24mo

Dimension breakdown

Safety Record

95.0MED

Funding Health

28.1HIGH

Market Presence

21.221.2LOW

IP Activity

11.6MED

Deployment Scale

7.8MED

Hiring Signal

0.0LOW

DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.

Last computed: Jul 3, 2026

Intelligence layer